UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)

CUSIP: 917488108

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
3,203,885
Total 13F shares
2,154,610
Share change
-76,542
Total reported value
$122,645,130
Price per share
$56.92
Number of holders
109
Value change
-$4,286,491
Number of buys
54
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 917488108?
CUSIP 917488108 identifies UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Kevin L. Cornwell
3/4/5
Chairman, CEO, Secretary, Director
class O/S missing
188,472
$17,774,794 22 Nov 2021
BRANDES INVESTMENT PARTNERS, LP
13F
Company
7.6%
242,249
$13,575,634 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F 13D/G
Company
6.7%
from 13D/G
217,714
$12,200,693 31 Mar 2025
DIMENSIONAL FUND ADVISORS LP
13D/G 13F
Company
6.1%
197,466
$11,239,863 $0 30 Jun 2025
VANGUARD GROUP INC
13F
Company
5.5%
176,367
$9,883,606 31 Mar 2025
13F
BlackRock, Inc.
13D/G 13F
Company
5.3%
172,684
$9,829,260 +$231,666 30 Jun 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
3.4%
107,776
$6,041,193 31 Mar 2025
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
3.2%
101,640
$5,695,906 31 Mar 2025
13F
Minerva Advisors LLC
13F
Company
2.7%
86,902
$4,869,988 31 Mar 2025
13F
FMR LLC
13D/G 13F
Company
2.7%
92,360
$4,848,900 $0 31 Dec 2024
STATE STREET CORP
13F
Company
2.5%
80,150
$4,516,434 31 Mar 2025
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
2.3%
73,795
$4,135,472 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
2.3%
72,329
$4,053,317 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
1.5%
48,612
$2,724,235 31 Mar 2025
13F
ROYCE & ASSOCIATES LP
13F
Company
1.3%
41,958
$2,351,326 31 Mar 2025
13F
Huber Capital Management LLC
13F
Company
1.2%
39,819
$2,231,456 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
1.1%
34,172
$1,914,999 31 Mar 2025
13F
ISTHMUS PARTNERS, LLC
13F
Company
1%
32,923
$1,845,005 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1%
32,008
$1,793,728 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.85%
27,296
$1,529,668 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.81%
25,905
$1,451,768 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.81%
25,895
$1,451,156 31 Mar 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.72%
23,100
$1,294,524 31 Mar 2025
13F
Cardinal Capital Management
13F
Company
0.68%
21,868
$1,232,140 31 Mar 2025
13F
BARD ASSOCIATES INC
13F
Company
0.66%
21,032
$1,184,547 31 Mar 2025
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.65%
20,928
$1,172,805 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.56%
17,950
$1,005,918 31 Mar 2025
13F
EVERETT HARRIS & CO /CA/
13F
Company
0.53%
17,116
$959,181 31 Mar 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.48%
15,470
$868,000 31 Mar 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.45%
14,408
$807,424 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.45%
14,286
$800,587 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.41%
13,268
$743,539 31 Mar 2025
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.41%
13,119
$735,189 31 Mar 2025
13F
LSV ASSET MANAGEMENT
13F
Company
0.37%
11,921
$668,000 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.32%
10,252
$574,522 31 Mar 2025
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.32%
10,154
$569,004 31 Mar 2025
13F
Atria Investments, Inc
13F
Company
0.31%
9,953
$557,766 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.3%
9,708
$544,036 31 Mar 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.27%
8,690
$486,988 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0.27%
8,535
$478,338 31 Mar 2025
13F
Ernst G. Hoyer
3/4/5
Director
class O/S missing
5,000
$471,550 23 Nov 2021
Barbara A. Payne
3/4/5
Director
class O/S missing
4,838
$456,272 08 Feb 2023
Nuveen, LLC
13F
Company
0.25%
8,018
$449,329 31 Mar 2025
13F
Sanctuary Advisors, LLC
13F
Company
0.24%
7,560
$423,662 31 Mar 2025
13F
Jump Financial, LLC
13F
Company
0.21%
6,608
$370,312 31 Mar 2025
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.2%
6,336
$355,069 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.18%
5,653
$316,794 31 Mar 2025
13F
SEIZERT CAPITAL PARTNERS, LLC
13F
Company
0.17%
5,569
$312,087 31 Mar 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.17%
5,328
$298,581 31 Mar 2025
13F
LPL Financial LLC
13F
Company
0.17%
5,298
$296,900 31 Mar 2025
13F

Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) as of Q2 2025

As of 30 Jun 2025, UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,154,610 shares. The largest 10 holders included BRANDES INVESTMENT PARTNERS, LP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, Minerva Advisors LLC, STATE STREET CORP, and RICE HALL JAMES & ASSOCIATES, LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
107
Q2 2025 holders
109
Holder diff
2
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .